FDA OKs First Interchangeable Insulin Biosimilar

(MedPage Today) -- The FDA approved Semglee (insulin glargine-yfgn) as the first interchangeable biosimilar insulin product for diabetes, allowing for pharmacy-level substitution in states that allow it, the agency announced on Wednesday.
"This...